![]() |
市场调查报告书
商品编码
1672937
药用塑胶瓶市场:按材料、瓶子类型、应用和地区划分Pharmaceutical Plastic Bottles Market, By Material, By Bottle Type, By Application, By Geography |
2025 年全球医药塑胶瓶市场价值预计为 110.6 亿美元,预计到 2032 年将达到 155.7 亿美元,2025 年至 2032 年的复合年增长率为 5.0%。
报告范围 | 报告详细信息 | ||
---|---|---|---|
基准年 | 2024 | 2025 年市场规模 | 110.6亿美元 |
效能资料 | 从 2020 年到 2024 年 | 预测期 | 2025 至 2032 年 |
预测期:2025-2032年复合年增长率: | 5.00% | 2032 年价值预测 | 155.7亿美元 |
由于全球製药和医疗保健行业对柔性和轻质包装的需求不断增加,全球医药塑胶瓶市场在过去几年中获得了显着的发展。医疗保健塑胶瓶在运输和储存过程中为药品和其他医疗保健产品提供有效的保护。它们采用聚对苯二甲酸乙二醇酯 (PET)、聚丙烯 (PP)、低密度聚乙烯 (LDPE)、高密度聚苯乙烯(HDPE) 和聚氯乙烯(PVC) 等塑胶聚合物製造而成,既耐用又轻巧。此外, 宝特瓶对水分、氧气和其他气体具有很强的渗透性,有助于保持药品更长时间的新鲜。这些优势推动了塑胶瓶在锭剂、胶囊、糖浆和其他药物製剂的初级包装中的应用。製药业的快速成长加上对有效药品包装的需求不断增长,预计将在未来几年推动对药用塑胶瓶的需求。
全球医药塑胶瓶市场主要受对药品有效和安全包装日益增长的需求的推动。塑胶瓶具有极佳的阻隔性水分、气体和微生物的能力,有助于延长药品的保存期限。塑胶瓶重量轻且灵活,方便运输和储存药品。用于製造瓶子的塑胶聚合物,例如聚对苯二甲酸乙二醇酯(PET)和高密度聚苯乙烯(HDPE),可回收且环保,因此比其他包装材料更受欢迎。然而,对塑胶使用的严格规定抑制了市场的成长。然而,开发生物基和生物分解性药品塑胶瓶的技术创新预计将在未来几年创造新的机会。
本研究报告对全球药用塑胶瓶市场进行了详细分析,并提供了预测期(2025-2032 年)的市场规模(十亿美元)和年复合成长率(CAGR%),假设 2024 年为基准年。
它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、业绩和策略等参数,对全球药用塑胶瓶市场的主要企业进行了概述。
研究中介绍的主要企业包括 Amcor Plc、Gerresheimer AG、AptarGroup, Inc.、Berry Global, Inc.、West Pharmaceutical Services, Inc.、RPC Group Plc、Sanner GmbH、Comar LLC、Alpack Plastics, Inc.、Indevco Group、山东民德塑胶有限公司、Hierak, Inc.
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球药用塑胶瓶市场报告迎合了该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员可以透过用于分析全球医药塑胶瓶市场的各种策略矩阵更轻鬆地做出决策。
Global Pharmaceutical Plastic Bottles Market is estimated to be valued at USD 11.06 Bn in 2025 and is expected to reach USD 15.57 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 11.06 Bn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 5.00% | 2032 Value Projection: | USD 15.57 Bn |
The global pharmaceutical plastic bottles market has been gaining significant traction over the past few years owing to the increasing demand for flexible and lightweight packaging in pharmaceutical and healthcare industries across the world. Pharmaceutical plastic bottles provide effective protection to medicines and other healthcare products during transportation and storage. They are manufactured using plastic polymers such as polyethylene terephthalate (PET), Polypropylene (PP), Low-Density Polyethylene (LDPE), high-density polyethylene (HDPE), and Polyvinyl Chloride (PVC) which make them durable yet lightweight. Moreover, plastic bottles help keep medicines fresh for a longer time due to their high impermeability to moisture, oxygen, and other gases. Such benefits have boosted the adoption of plastic bottles in primary packaging of tablets, capsules, syrups, and other pharmaceutical formulations. Rapid growth of the pharmaceutical sector coupled with rising need for effective medicine packaging is expected to continue driving the demand for pharmaceutical plastic bottles in the coming years.
The global pharmaceutical plastic bottles market is primarily driven by the rising demand for effective and safe packaging of pharmaceutical products. Plastic bottles offer excellent barrier properties against moisture, gases, and microbes, which helps extend the shelf life of medicines. Their lightweight and flexible nature make plastic bottles convenient for transportation and storage of medicines. Plastic polymers used in bottle manufacturing, such as Polyethylene Terephthalate (PET) and High-Density Polyethylene (HDPE), are recyclable and environment-friendly, which has further increased their preference over other packaging materials. However, stringent regulations pertaining to the use of plastic are restraining the market growth. Nevertheless, innovations toward developing bio-based and biodegradable pharmaceutical plastic bottles are expected to create new opportunities over the coming years.
This report provides in-depth analysis of the global pharmaceutical plastic bottles market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pharmaceutical plastic bottles market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Amcor Plc, Gerresheimer AG, AptarGroup, Inc., Berry Global, Inc., West Pharmaceutical Services, Inc., RPC Group Plc, Sanner GmbH, Comar LLC, Alpack Plastics, Inc., Indevco Group, Shandong Minde Plastic Co., Ltd., HCP Packaging, Shenzhen Dazheng Printing Co., Ltd., Sidel Group, and Plastipak Holdings, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pharmaceutical plastic bottles market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical plastic bottles market